MY195821A - Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers - Google Patents
Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other CancersInfo
- Publication number
- MY195821A MY195821A MYPI2019004578A MYPI2019004578A MY195821A MY 195821 A MY195821 A MY 195821A MY PI2019004578 A MYPI2019004578 A MY PI2019004578A MY PI2019004578 A MYPI2019004578 A MY PI2019004578A MY 195821 A MY195821 A MY 195821A
- Authority
- MY
- Malaysia
- Prior art keywords
- peptides
- cells
- tumor
- present
- relates
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor- associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules. In particular, the present invention relates to several novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses or as targets for the development of pharmaceutically / immunologically active compounds and cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
MY195821A true MY195821A (en) | 2023-02-22 |
Family
ID=87569450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY195821A (en) |
-
2019
- 2019-08-08 MY MYPI2019004578A patent/MY195821A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500484A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
PH12021550205A1 (en) | Immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methods | |
PH12019502308A1 (en) | Peptides and combination thereof for use in the immunotherapy against cancers | |
PH12021550346A1 (en) | B*44 restricted peptides for use in immunotherapy against cancers and related methods | |
PH12020500051A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers | |
PH12021550581A1 (en) | Immunotherapy with a*01 restricted peptides and combination of peptides against cancers and related methods | |
PH12020552013A1 (en) | A*03 restricted peptides for use in immunotherapy against cancers and related methods | |
PH12020551958A1 (en) | Peptides for use in immunotherapy against cancers | |
CR20210329A (en) | Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods | |
MX2020005188A (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers. | |
MY195821A (en) | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers | |
MY197679A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
MY197301A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
MY197794A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
CR20200477A (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors |